() () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () ()

Tag Archives: DionyMed Brands

DionyMed Brands Inc. Signs Definitive Agreement with Premium Manufacturer and Indoor Craft Cultivator Waterside Warehousing

DionyMed Brands Inc. (“DionyMed” or “Company”) (CSE:DYME; OTCQB:HMDEF), a multi-state cannabis brands platform, announced in an arms-length transaction today it has signed a definitive agreement with an irrevocable option to acquire Waterside Warehousing (“Waterside”), a premium manufacturer and indoor craft cultivator located in Oakland, California. DYME has agreed to provide US $1 million up front, which DionyMed can finance using its credit facility, with the option to acquire Waterside for an additional US $5 million.
Read more

DionyMed Brands Inc. Announces Expansion of Its Cannabis Brand Portfolio

DionyMed Brands Inc. (“DionyMed” or “Company”) (CSE: DYME), a multi-state cannabis brands, distribution and delivery platform, announced today the expansion of its wholly-owned, award-winning brand, Winberry Farms, to offer consumers an even more comprehensive, diversified product portfolio with 12 new CBD-focused products. With these new additions, the Winberry Farms product line will encompass 75 high-quality distillate and full-spectrum THC and CBD concentrates, currently available in 300 retail locations in Oregon and 50 locations in California. One of the first recreational cannabis farms to be licensed by the state of Oregon, Winberry Farms specializes in expertly-cultivated, naturally sun-grown product.
Read more

DionyMed Brands Inc. Signs Definitive Agreement for an up to US$40 Million Credit Facility

DionyMed Brands Inc. (“DionyMed” or “Company”) (CSE:DYME), a multi-state cannabis brand and delivery platform, today announced it has signed a definitive agreement (the “Agreement”) for a two-year, up to US$40 million senior secured credit facility from a syndicate of investors. The credit facility consists of a US$15 million term loan facility and a US$25 million asset-backed loan facility. DionyMed will draw US$13 million following the completion of certain conditions to the satisfaction of the investors. Currently, the syndicate of investors have committed to provide US$13 million of the credit facility. Future commitments from existing or future lenders are expected for the full amount.
Read more